Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.

[1]  M. Kurosaki,et al.  Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis , 2011, Journal of Gastroenterology.

[2]  N. Enomoto,et al.  Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. , 2011, Journal of hepatology.

[3]  M. Kurosaki,et al.  Sequences in the interferon sensitivity‐determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG‐interferon plus ribavirin: Data mining analysis , 2011, Journal of medical virology.

[4]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[5]  M. Kurosaki,et al.  Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis , 2011, Journal of Gastroenterology.

[6]  M. Kurosaki,et al.  Predictors of Virological Response to a Combination Therapy with Pegylated Interferon Plus Ribavirin Including Virus and Host Factors , 2010, Hepatitis research and treatment.

[7]  N. Enomoto,et al.  Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[8]  N. Enomoto,et al.  Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection , 2010, Hepatology.

[9]  Pierre Bedossa,et al.  Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis. , 2010, Journal of hepatology.

[10]  Hiroki Ikeda,et al.  A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  Jean-Michel Pawlotsky,et al.  Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. , 2009, The New England journal of medicine.

[12]  D. Harnois.  Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease , 2009 .

[13]  D. Harnois.  Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection , 2009 .

[14]  A. Mangia,et al.  Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study , 2007, Hepatology.

[15]  K. Hatakeyama,et al.  Prognostic Groups in Colorectal Carcinoma Patients Based on Tumor Cell Proliferation and Classification and Regression Tree (CART) Survival Analysis , 2006, Annals of surgical oncology.

[16]  Sheng-Nan Lu,et al.  Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high‐risk for hepatocellular carcinoma , 2006, Cancer.

[17]  M. Mori,et al.  Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies , 2005, Cancer.

[18]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[19]  Nilima Nigam,et al.  A Predictive Model of Rectal Tumor Response to Preoperative Radiotherapy Using Classification and Regression Tree Methods , 2005, Clinical Cancer Research.

[20]  A. Craxì,et al.  Prevention of hepatocellular carcinoma. , 2005, Clinics in liver disease.

[21]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[22]  Y. Ohashi,et al.  Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival , 2005, Annals of Internal Medicine.

[23]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[24]  Claus Garbe,et al.  Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  M. Sata,et al.  Answer , 2004, Gut.

[26]  J. Gornbein,et al.  Phosphorus ans an early predictive factor in patients with acute liver failure1 , 2003, Transplantation.

[27]  L. Rodrigo,et al.  Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis , 2003, Hepatology.

[28]  J Sunil Rao,et al.  A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging. , 2002, Surgery.

[29]  I. Takei,et al.  Novel statistical classification model of type 2 diabetes mellitus patients for tailor-made prevention using data mining algorithm. , 2002, Journal of epidemiology.

[30]  S Chevret,et al.  Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death , 2000, Gut.

[31]  J. Griffith,et al.  A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C , 1999, American Journal of Gastroenterology.

[32]  D. Häussinger,et al.  Prognosis of chronic hepatitis c: Results of a large, prospective cohort study , 1998, Hepatology.

[33]  A. Bhalla,et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.

[34]  C. Chastang,et al.  Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis , 1996, Hepatology.

[35]  S. Seki,et al.  Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis , 1995, The Lancet.

[36]  M LeBlanc,et al.  A review of tree-based prognostic models. , 1995, Cancer treatment and research.

[37]  Leo Breiman,et al.  Classification and Regression Trees , 1984 .